Unlocking the potential of mRNA for the future treatment of rare diseases
Drug Discovery World
FEBRUARY 28, 2023
Moderna Therapeutics, a biotechnology company that has developed SARS-CoV-2 mRNA vaccines, has at least six rare disease programmes currently in preclinical and clinical development (Table 1). She is passionate about advancing research in the pursuit of healthier lives for all.
52 
Let's personalize your content